Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (361-370 of 768) with videos related to

Pageof 77
Sort By:
Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.
Blood|January 1, 1992
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcomeE Gluckman, M M Horowitz, R E Champlin, et al.
Experimental Hematology|May 8, 2013
Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implicationsBenigno C Valdez, Guiyun Wang, David Murray, et al.
American Journal of Hematology|February 3, 2023
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDSCurtis Marcoux, David Marin, Jeremy Ramdial, et al.
Blood|July 27, 2007
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemiaPartow Kebriaei, Michelle A Detry, Sergio Giralt, et al.
Blood Advances|November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patientsBetül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Cytotherapy|July 12, 2021
Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood bankingJoanie Hare, Paulina Garcia DeLeon, Krystle Pool, et al.
Journal of Hematology & Oncology|February 7, 2013
Validation of the M. D. Anderson Symptom Inventory multiple myeloma moduleDesiree Jones, Elisabeth G Vichaya, Xin Shelley Wang, et al.
Transplantation and Cellular Therapy|March 29, 2023
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid LeukemiaRohtesh S Mehta, Jeremy Ramdial, David Marin, et al.
Blood|February 1, 1989
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment resultsR E Champlin, M M Horowitz, D W van Bekkum, et al.
Pageof 77

Showing results (361-370 of 768) with videos related to

Sort By:
Pageof 77
Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.
Blood|January 1, 1992
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcomeE Gluckman, M M Horowitz, R E Champlin, et al.
Experimental Hematology|May 8, 2013
Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: relevance of p53 and its clinical implicationsBenigno C Valdez, Guiyun Wang, David Murray, et al.
American Journal of Hematology|February 3, 2023
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDSCurtis Marcoux, David Marin, Jeremy Ramdial, et al.
Blood|July 27, 2007
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemiaPartow Kebriaei, Michelle A Detry, Sergio Giralt, et al.
Blood Advances|November 10, 2020
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patientsBetül Oran, Marcos de Lima, Guillermo Garcia-Manero, et al.
Cytotherapy|July 12, 2021
Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood bankingJoanie Hare, Paulina Garcia DeLeon, Krystle Pool, et al.
Journal of Hematology & Oncology|February 7, 2013
Validation of the M. D. Anderson Symptom Inventory multiple myeloma moduleDesiree Jones, Elisabeth G Vichaya, Xin Shelley Wang, et al.
Transplantation and Cellular Therapy|March 29, 2023
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid LeukemiaRohtesh S Mehta, Jeremy Ramdial, David Marin, et al.
Blood|February 1, 1989
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment resultsR E Champlin, M M Horowitz, D W van Bekkum, et al.
Pageof 77